Iron-doped boron nitride nanocage for targeted delivery of 5 fluorouracil: A DFT guided experimental study with in vitro validation
Archives of Advances in Biosciences,
Vol. 17 No. 1 (2026),
28 Ordibehesht 2026
,
Page 1-17
https://doi.org/10.22037/aab.v17i1.52105
Abstract
Background and Aim: 5-Fluorouracil (5-FU) is a widely used anticancer drug but suffers from severe systemic toxicity, short half-life, and low tumor selectivity. Boron nitride nanocages have emerged as promising drug delivery vehicles due to their high biocompatibility and low cytotoxicity. Transition metal doping, particularly with iron, can enhance drug binding affinity through electronic effects.
The purpose of this study was to evaluate the potential of iron-doped boron nitride nanocage (NC Fe) as a nanocarrier for targeted delivery of 5-FU using a multiscale approach combining DFT calculations, experimental adsorption studies, and in vitro cellular/molecular assays.
Methods: DFT calculations at the B3LYP/6 31G(d) level were performed to determine the interaction energy, QTAIM parameters, NBO charge transfer, and HOMO LUMO gap of the FU-NC-Fe complex. Batch adsorption experiments were conducted to optimize pH, contact time, initial drug concentration, and adsorbent dosage. MTT assay, flow cytometry (Annexin V FITC/PI staining), and qRT-PCR (Bax and Bcl-2 expression) were performed on MCF-7 breast cancer cells and normal HFF fibroblasts.
Results: DFT calculations revealed a negative interaction energy of –59.8 kJ/mol with positive ∇²ρ(r) (0.098 a.u.), confirming spontaneous noncovalent binding. Bidirectional charge transfer of 0.29 electrons and an 11.8% reduction in HOMO LUMO gap were observed. Optimal adsorption conditions (pH 7.0, 30 min, 20 mg/L, 0.10 g NC Fe) yielded 76.5% adsorption efficiency. FU-NC-Fe exhibited significantly enhanced cytotoxicity against MCF- 7 cells (IC₅₀ = 8.7 µg/mL) compared to free 5-FU (18.4 µg/mL), with a selectivity index of 4.86. The complex induced 52.7% total apoptosis (vs. 28.4% for free drug) and increased the Bax/Bcl-2 ratio 4.5 fold (21.3 vs. 4.7). Pristine NC-Fe showed excellent biocompatibility (IC₅₀ > 200 µg/mL).
Conclusion: Iron-doped boron nitride nanocage is a highly promising nanocarrier for targeted 5-FU delivery, offering enhanced anticancer efficacy, high cancer cell selectivity, and potent apoptosis induction through the mitochondrial pathway.
- 5 Fluorouracil
- Boron nitride nanocage
- Iron doping
- Drug delivery
- DFT
- Breast cancer
- Apoptosis
How to Cite
References
1. Javan MB, Soltani A, Azmoodeh Z, Abdolahi N, Gholami N. A DFT study on the interaction between 5-fluorouracil and B12N12 nanocluster. RSC Adv. 2016;6(106):104513-21. (DOI: 10.1039/C6RA18196A)
2. Soliman KA, Aal SA. Theoretical investigation of favipiravir antiviral drug based on fullerene and boron nitride nanocages. Diam relat mater. 2021;117:108458. (DOI: 10.1016/j.diamond.2021.108458) (PMID: 34025036)
3. Bader RFW. Atoms in molecules. Acc chem res. 1985;18(1):9-15. (DOI:10.1021/ar00109a003)
4. Reed AE, Curtiss LA, Weinhold F. Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint. Chem rev. 1988;88(6):899-926. (DOI: 10.1021/cr00088a005)
5. Arabi Z, Gholami M, Zare K. Interaction of 5-fluorouracil with functionalized carbon nanotubes: a molecular dynamics simulation study. Sci rep. 2021;11(1):1-12. Link
6. Beheshtian J, Peyghan AA, Bagheri Z. DFT study of the interaction of 5-fluorouracil with BN nanotubes. J mol model. 2013;19(5):2197-203. (DOI: 10.1007/s00894-012-1751-2) (PMID: 23354475)
7. Li H, Heravi MR, Ebadi AG, Ahmadi S, Sarkar A. Study the nature of the interaction between 5-fluorouracil anti-cancer drug and zinc oxide nanocage. Braz j phys. 2022;52(2):53. (DOI:10.1007/s13538-022-01062-2)
8. Zhang L, Wang Y, Chen X. Molecular dynamics simulation of doxorubicin and camptothecin interactions with carbon nanotubes. J mol liq. 2023;345:117032. Link
9. Provin P, Khan M, Ahmadi S. Graphene as a carrier for doxorubicin drug delivery: a DFT study. Diam relat mater. 2023;132:109654. Link
10. Yousefi M, Rad MS, Shakibazadeh R, Ghodrati L, Kachoie MA. Simulating a heteroatomic CBN fullerene-like nanocage towards the drug delivery of fluorouracil. Mol simul. 2022;48(14):1284-92. (DOI:10.1080/08927022.2022.2086252)
11. Ciofani G, Danti S, D'Alessandro D, Moscato S, Menciassi A. Boron nitride nanotubes: biocompatibility and potential spill-over in nanomedicine. Small. 2010;6(21):2400-7. (DOI: 10.1002/smll.201201315) (PMID: 23423826)
12. Ferreira TH, Neves MC, Sousa EM, Soares DC. Boron nitride nanotubes in nanomedicine: functionalization and applications. Nanomedicine. 2015;10(16):2595-610. Link
13. Li R, Wang Y. Modification of boron nitride nanocages by titanium doping results unexpectedly in exohedral complexes. Nat commun. 2019;10(1):4908. (DOI: 10.1038/s41467-019-12877-0) (PMID: 31659166)
14. Yang X, Zhou S, Huang S, Zhao J. Metal-encapsulated boron nitride nanocages for solar-driven nitrogen fixation. J phys chem c. 2020;124(43):23798-806. (DOI:10.1021/acs.jpcc.0c07968)
15. Esrafili MD, Nurazar R. A comparative DFT study on the interaction of 5-fluorouracil with B12N12 and Al12N12 nanocages. J mol graph model. 2018;82:158-64. Link
16. Shariat M, Khodabakhshi MR. DFT investigation of 5-fluorouracil adsorption on boron nitride nanocages. J nanostruct chem. 2019;9(3):251-60. Link
17. Nejati K, Rezvani Z, Seyedahmadian E. A DFT study on the interaction of uracil and its derivatives with B12N12 nanocage. J mol liq. 2020;314:113654. Link
18. Sedighi M, Noori M, Shamlouei A. Computational study of drug delivery systems based on boron nitride nanocages. J mol struct. 2022;1258:132650. Link
19. Diznab HA, Javan MB, Soltani A, Gharibzadeh F. A comparative DFT study on the interaction of anticancer drugs with boron nitride nanocages. Appl surf sci. 2022;585:152624. Link
20. Fan X, Li Z. Adsorption of 5-fluorouracil on boron nitride nanocages: a DFT study with solvent effects. J Mol Liq. 2021;328:115432. Link
21. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat rev cancer. 2003;3(5):330-8. (DOI: 10.1038/nrc1074) (PMID: 12724731)
22. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, et al. Fluorinated pyrimidines a new class of tumour-inhibitory compounds. Nature. 1957;179(4561):663-6. (DOI: 10.1038/179663a0) (PMID: 13418758)
23. Pałasz A, Cież D. In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications. Eur j med chem. 2015;97:582-611. (DOI: 10.1016/j.ejmech.2014.10.008) (PMID: 25306174)
24. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J nanobiotechnology. 2018;16(1):1-33. (DOI: 10.1186/s12951-018-0392-8) (PMID: 30231877)
25. Mu W, Chu Q, Liu Y, Zhang N. A review on nano-based drug delivery system for cancer chemoimmunotherapy. Nano-micro lett. 2020;12(1):142. (DOI: 10.1007/s40820-020-00482-6) (PMID: 34138136)
26. Sultana A, Zare M, Thomas V, Kumar TS, Ramakrishna S. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects. Med drug discov. 2022;15:100134. (DOI: 10.1016/j.medidd.2022.100134)
27. Wang X, Zhi C, Weng Q, Bando Y, Golberg D. Boron nitride nanotubes: synthesis, properties and applications. Nanoscale. 2018;10(33):15473-95. Link
28. Kim JH, Kim MJ, Park JY. Boron nitride nanotubes: a review of recent progress on biomedical applications. Nanomaterials. 2020;10(7):1360. Link
29. Golberg D, Bando Y, Huang Y, Terao T, Mitome M, Tang C, et al. Boron nitride nanotubes and nanosheets. ACS nano. 2010;4(6):2979-93. (DOI: 10.1021/nn1006495) (PMID: 20462272)
30. Khosravi A, Baei MT, Sayyed-Alangi SZ, Tazikeh Lemeski E. DFT-guided design of hydroxytyrosol-encapsulated nanocages: comparative insights into boron nitride versus carbon fullerenes for targeted drug delivery and therapeutic applications. Adv theory simul. 2025. Link
31. Rahimi M, Wali AF, Talath S, Aljasser A, Aldurdunji MM, Alqahtani F, et al. DFT investigation of iron-doped boron nitride nanoparticles for anastrozole drug delivery and molecular interaction. Sci rep. 2025;15(1):8670. (DOI: 10.1038/s41598-025-92888-8 ) (PMID: 40082535)
32. Moumivand A, Naderi F, Moradi O, Makiabadi B. Smart drug delivery: a DFT study of C₂₄ fullerene and doped analogs for pyrazinamide. Nanoscale adv. 2025;7(5):1287-1299. (DOI: 10.1039/D4NA00560K ) (PMID: 39802333)
33. Guo L, Chen C, Luo Y, Zuo K, Guo Z, Tang D. Theranostic potential of metal-doped B₃₆N₃₆ nanocages for β-lapachone delivery: A density functional theory study. J mol liq. 2025. Link
34. Opi MH, Ahmed T, Swarna MR, Piya AA, Shamim SUD. Assessment of the drug delivery potential of graphene, boron nitride and their in-plane doped structures for hydroxyurea anti-cancer drug via DFT study. Nanoscale Adv. 2024;6(20):5042-5054. (DOI: 10.1039/D4NA00428K ) (PMID: 39148501)
35. Saha SK, Nishat M, Mostofa MR, Hasnat MA, Al-Amin. The adsorption effect of an anti-diabetic drug on the surface of B₁₂N₁₂ and XB₁₁N₁₂ (X = Ga, Al, In) nanocages: A comparative DFT study with COSMO insights. Chem phys lett. 2025;878:142332. (DOI: 10.1016/j.cplett.2025.142332)
- Abstract Viewed: 14 times